Is Mezzion PharmaLtd (KOSDAQ:140410) A Risky Investment?
Feb 06
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedMar 16, 2026
DataAggregated Company Financials
Companies105
- 7D-1.0%
- 3M17.8%
- 1Y53.5%
- YTDn/a
Last week, the Pharma industry hasn't moved much but Oscotec is up 17% in that time. As for the the longer term, the industry is up 54% over the past 12 months. As for the next few years, earnings are expected to grow by 37% per annum.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 16 Mar 2026 | ₩85.7t | ₩31.5t | ₩1.3t | 15.5x | 67.9x | 2.7x |
| Wed, 11 Feb 2026 | ₩84.5t | ₩31.4t | ₩1.2t | 16.1x | 71.3x | 2.7x |
| Fri, 09 Jan 2026 | ₩71.5t | ₩31.4t | ₩1.2t | 16.2x | 60.3x | 2.3x |
| Sun, 07 Dec 2025 | ₩72.4t | ₩31.7t | ₩1.2t | 14.7x | 60.4x | 2.3x |
| Tue, 04 Nov 2025 | ₩66.8t | ₩31.3t | ₩1.0t | 18.3x | 66.5x | 2.1x |
| Thu, 02 Oct 2025 | ₩64.3t | ₩31.1t | ₩925.9b | 20.2x | 69.4x | 2.1x |
| Sat, 30 Aug 2025 | ₩58.6t | ₩31.0t | ₩932.2b | 19.2x | 62.8x | 1.9x |
| Mon, 28 Jul 2025 | ₩60.6t | ₩30.4t | ₩918.0b | 17.5x | 66x | 2x |
| Wed, 25 Jun 2025 | ₩54.1t | ₩30.1t | ₩903.8b | 16x | 59.8x | 1.8x |
| Fri, 23 May 2025 | ₩52.9t | ₩29.6t | ₩949.5b | 17.4x | 55.8x | 1.8x |
| Sun, 20 Apr 2025 | ₩52.9t | ₩29.6t | ₩984.4b | 17.9x | 53.7x | 1.8x |
| Tue, 18 Mar 2025 | ₩55.2t | ₩29.7t | ₩958.8b | 14.1x | 57.6x | 1.9x |
| Thu, 13 Feb 2025 | ₩56.3t | ₩29.6t | ₩1.0t | 11.6x | 55.1x | 1.9x |
| Sat, 11 Jan 2025 | ₩57.6t | ₩29.6t | ₩1.0t | 13.4x | 56.7x | 1.9x |
| Mon, 09 Dec 2024 | ₩50.3t | ₩29.4t | ₩1.0t | 11.4x | 50.2x | 1.7x |
| Wed, 06 Nov 2024 | ₩59.8t | ₩28.7t | ₩841.1b | 15.4x | 71x | 2.1x |
| Fri, 04 Oct 2024 | ₩57.9t | ₩28.7t | ₩833.2b | 14.5x | 69.4x | 2x |
| Sun, 01 Sep 2024 | ₩61.4t | ₩28.8t | ₩838.8b | 15.4x | 73.2x | 2.1x |
| Tue, 30 Jul 2024 | ₩56.4t | ₩28.4t | ₩762.2b | 14.9x | 74x | 2x |
| Thu, 27 Jun 2024 | ₩52.3t | ₩30.0t | ₩904.2b | 13.1x | 57.9x | 1.7x |
| Sat, 25 May 2024 | ₩52.4t | ₩29.7t | ₩928.5b | 16.6x | 56.4x | 1.8x |
| Mon, 22 Apr 2024 | ₩49.7t | ₩29.4t | ₩922.9b | 16.2x | 53.9x | 1.7x |
| Wed, 20 Mar 2024 | ₩54.2t | ₩29.7t | ₩772.5b | 21.4x | 70.1x | 1.8x |
| Fri, 16 Feb 2024 | ₩51.5t | ₩29.6t | ₩593.1b | 21x | 86.8x | 1.7x |
| Sun, 14 Jan 2024 | ₩53.6t | ₩29.6t | ₩588.5b | 23.1x | 91.1x | 1.8x |
| Tue, 12 Dec 2023 | ₩50.5t | ₩29.6t | ₩587.6b | 21.8x | 85.9x | 1.7x |
| Thu, 09 Nov 2023 | ₩49.5t | ₩29.3t | ₩683.3b | 16.6x | 72.5x | 1.7x |
| Sat, 07 Oct 2023 | ₩51.0t | ₩29.3t | ₩683.3b | 17x | 74.7x | 1.7x |
| Mon, 04 Sep 2023 | ₩49.8t | ₩29.3t | ₩683.9b | 15.9x | 72.8x | 1.7x |
| Wed, 02 Aug 2023 | ₩51.0t | ₩28.8t | ₩884.1b | 21.3x | 57.7x | 1.8x |
| Fri, 30 Jun 2023 | ₩47.0t | ₩28.9t | ₩908.3b | 20.8x | 51.7x | 1.6x |
| Sun, 28 May 2023 | ₩47.7t | ₩28.9t | ₩902.3b | 22.6x | 52.9x | 1.7x |
| Tue, 25 Apr 2023 | ₩47.6t | ₩28.5t | ₩602.7b | 20.8x | 79.1x | 1.7x |
| Thu, 23 Mar 2023 | ₩44.9t | ₩27.9t | ₩680.0b | 18.8x | 66x | 1.6x |
Price to Earnings Ratio
66x
Current Industry PE
- Investors are relatively neutral on the South Korean Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 65.8x.
- The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 23% per year over the last three years.
- Revenues for these companies have grown 4.2% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does South Korean Pharma compare with similar industries?
| KR Market | -1.56% | |
| Healthcare | -0.52% | |
| Pharma | -0.97% | |
| Pharma | -0.97% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A039200 Oscotec | ₩59.30k | 17.4% +₩336.7b | 91.0% | PS97.6x | |
| A128940 Hanmi Pharm | ₩500.00k | 3.8% +₩234.6b | 103.3% | PE54.4x | |
| A084110 Huons Global | ₩74.40k | 16.4% +₩128.1b | 56.8% | PE37.2x | |
| A003000 Bukwang Pharmaceutical | ₩5.94k | 20.1% +₩98.2b | 28.9% | PE60.2x | |
| A102940 Kolon Life Science | ₩62.50k | 10.0% +₩74.5b | 79.6% | PE45.9x |